chimaerin Antibodies

Santa Cruz Biotechnology provides a broad selection of chimaerin monoclonal antibodies for research applications. Chimaerins are essential proteins that regulate cellular signaling pathways, particularly in neuronal development and function. The role of chimaerins in modulating Rho GTPases makes them critical components in cytoskeletal dynamics and cell migration. chimaerin Antibodies targeting chimaerins are compatible with multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Studying chimaerins has revealed significant insights into neurodegenerative diseases and cancer development. Researchers worldwide utilize chimaerin monoclonal antibodies to investigate cellular mechanisms and potential therapeutic targets. Understanding chimaerin function continues to advance knowledge in both normal physiological processes and disease states. Santa Cruz Biotechnology monoclonal antibodies targeting chimaerins enable researchers to make meaningful contributions to scientific understanding and potential therapeutic developments.